Article · Journal · 2025

Assessing the efficacy of darolutamide in metastatic hormone-sensitive prostate cancer based on subgroup meta-analysis and reconstructed individual patient data

Discover Oncology

Citations: 1from other works
Field-weighted impact: 0.611.00 is the world average for its field and year
Among its field: 72nd percentileby citations, against works of its field and year
Authors: 11from 6 institutions

Authors

11 authors across 6 institutions in 3 countries